Twist Bioscience Corp faced significant pressure in the market as its stock fell sharply, raising concerns among investors.
Twist Bioscience Corp (NASDAQ:TWST) experienced a notable decline yesterday, with shares dropping by 6.78%. This downturn has sparked discussions about the company's future and the broader implications for the biotech sector.
Advertisement
Twist Bioscience Corp
TWST.US
TWST.US
Twist Bioscience Corp
WealthAwesomeMarket cap
$9.46B
52W high
$219.71
52W low
$23.30
1W change
-5.70%
Beta
2.19
Analyst Price Targets
Based on 13 analysts covering TWST · as of Oct 14, 2026
Wall Street analysts forecast TWST stock price to rise 14.7% over the next 12 months.
Consensus
Buy4.08 / 5.00
Avg. Target
C$163.67
+14.7% Upside
Previously C$157.42 on Oct 13, 2026
Current Price
C$142.70
Last close
Analyst Breakdown (13 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TWST's historical volatility
30-Day Vol
100.7%
Annualized
90-Day Vol
91.7%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$178.29
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$158.28 | C$111.81 – C$224.05 |
| 60 trading days | C$167.98 | C$102.76 – C$274.62 |
| 90 trading days | C$178.29 | C$97.65 – C$325.50 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the recent performance and market sentiment around Twist Bioscience, particularly in light of its ongoing challenges in the competitive biotech landscape.
6.78% decline in stock price
Twist Bioscience's stock has been under pressure, reflecting investor skepticism about its growth potential amidst a challenging market environment.
Bull case
Analysts see potential for Twist Bioscience to benefit from AI-driven drug discovery, which could strengthen its market position and lead to future growth.
Bear case
The recent stock performance raises concerns about the company's valuation, especially given its ongoing losses and the competitive pressures within the biotech industry.
Market Reaction and Analyst Sentiment
Advertisement
The sharp decline in Twist Bioscience's stock is due to a mix of factors, including market volatility and investor worries about the company's long-term growth. Analysts have mixed feelings; some highlight the promise of AI-driven drug discovery, while others warn against overvaluation given the company's current financial struggles.
Challenges Facing Twist Bioscience
Twist Bioscience continues to face significant challenges, including ongoing losses and intense competition in the biotech sector. The company's recent performance has raised questions about its ability to sustain growth and profitability, especially as it navigates a rapidly evolving landscape that demands innovation and efficiency.
Future Outlook
Looking ahead, investors will need to closely monitor Twist Bioscience's strategic initiatives and market developments. The company's ability to leverage AI technologies and improve its financial performance will be critical in determining its stock trajectory and overall market confidence.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
